In this review article, published in the journal Immunotherapy, the authors explore immunotherapy for neuroblastoma from therapeutic backbone to the latest discoveries.
Take a look behind the scenes of a recent paper in Biomarkers in Medicine as we ask the author about oligomeric α-synuclein in basal tears of Parkinson’s patients.
In this Editorial published in Immunotherapy, researchers explore the use of antibodies directed against amyloid-β oligomers for Alzheimer’s disease.
What is the optimal treatment for Duchenne muscular dystrophy in the MENA region? Find out in this paper published by Neurodegenerative Disease Management.
Whilst at the ARUK Conference 2019, we had the pleasure of speaking with Hugh Perry about neuroinflammation and Alzheimer’s disease, particularly the role of microglia in brain homeostasis.
In this commentary from Future Neurology, the authors overview and compare cerebral organoids and other 3D aggregated cell cultures.
In this report from Future Neurology, researchers describe the application and state of development of a range of CSF biomarkers in common neurodegenerative disorders.
In this review from Biomarkers in Medicine, researchers demonstrate that PARK7 and NDKA could present more clinical important information as biomarkers for management of stroke disease.
Take a look behind the scenes of a recent CNS Oncology paper as we ask the authors about the Nativis Voyager® for the treatment of glioblastoma.